BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 21925220)

  • 1. Toxicology of nanoparticles.
    Elsaesser A; Howard CV
    Adv Drug Deliv Rev; 2012 Feb; 64(2):129-37. PubMed ID: 21925220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications.
    Ju-Nam Y; Lead JR
    Sci Total Environ; 2008 Aug; 400(1-3):396-414. PubMed ID: 18715626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The devil is in the details (or the surface): impact of surface structure and surface energetics on understanding the behavior of nanomaterials in the environment.
    Mudunkotuwa IA; Grassian VH
    J Environ Monit; 2011 May; 13(5):1135-44. PubMed ID: 21523296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in assessing nanomaterial toxicology: a personal perspective.
    Geraci CL; Castranova V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):569-77. PubMed ID: 20799267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S; Hayes A; Dechsakulthorn F
    Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management.
    Warheit DB; Reed KL; Sayes CM
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():61-7. PubMed ID: 19558235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
    Warheit DB; Sayes CM; Reed KL; Swain KA
    Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of engineered nanoparticles with various components of the environment and possible strategies for their risk assessment.
    Bhatt I; Tripathi BN
    Chemosphere; 2011 Jan; 82(3):308-17. PubMed ID: 20980041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin, separation and identification of environmental nanoparticles: a review.
    Tsao TM; Chen YM; Wang MK
    J Environ Monit; 2011 May; 13(5):1156-63. PubMed ID: 21505694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?
    Moore MN
    Environ Int; 2006 Dec; 32(8):967-76. PubMed ID: 16859745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles: their potential toxicity, waste and environmental management.
    Bystrzejewska-Piotrowska G; Golimowski J; Urban PL
    Waste Manag; 2009 Sep; 29(9):2587-95. PubMed ID: 19427190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical methods to assess nanoparticle toxicity.
    Marquis BJ; Love SA; Braun KL; Haynes CL
    Analyst; 2009 Mar; 134(3):425-39. PubMed ID: 19238274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of nanoparticle dissolution and its importance in nanotoxicological studies.
    Misra SK; Dybowska A; Berhanu D; Luoma SN; Valsami-Jones E
    Sci Total Environ; 2012 Nov; 438():225-32. PubMed ID: 23000548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormetic dose-responses in nanotechnology studies.
    Iavicoli I; Fontana L; Leso V; Calabrese EJ
    Sci Total Environ; 2014 Jul; 487():361-74. PubMed ID: 24793332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental implications of nanoparticle aging in the processing and fate of copper-based nanomaterials.
    Mudunkotuwa IA; Pettibone JM; Grassian VH
    Environ Sci Technol; 2012 Jul; 46(13):7001-10. PubMed ID: 22280489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential hazard of nanoparticles: from properties to biological and environmental effects.
    Kahru A; Savolainen K
    Toxicology; 2010 Mar; 269(2-3):89-91. PubMed ID: 20176073
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems.
    Keck CM; Müller RH
    Eur J Pharm Biopharm; 2013 Aug; 84(3):445-8. PubMed ID: 23333302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.